The Antibody Discovery Specialist.

At Abveris, we are antibody enthusiasts discovering biologics that target the most challenging classes of therapeutic targets.


Learn about our platform




100+ Successful Discovery Campaigns Targeting Cell Surface receptors.

Industry-leading solutions for therapeutic and reagent antibody developers. We have built a strong reputation on our ability to deliver outstanding science. We have custom-built gene-to-antibody solutions to support development efforts for:

  • Therapeutic antibodies against difficult targets such as GPCR, ion channels, glycan targets
  • Cell therapies
  • Point-of-care diagnostics
  • Reagent & anti-idiotypic antibodies supporting clinical trials
  • Anywhere else antibodies are needed
ForteBio Octet Trianni Berkeley Lights Screen Shot 2020-04-19 at 7.11.42 PM logo-carterra intellicyt ACRO_LOGO (1) Harbour Biomed Logo Hamilton logo Tecan-logo

The Reviews Are In.

8/10 top pharmas & dozens of smaller groups rely on Abveris.

"We counted on Abveris to generate antibodies against a difficult target and we received numerous antibodies that resulted in several functional leads to progress a high priority program. Have seen similar results in subsequent projects. Abveris is an essential element to our research efforts."

Ramesh Bhatt, PhD

Head of Research & Co-Founder
Torch Therapeutics

Speak with Abveris scientists about how to tackle challenges in antibody discovery.

Abveris News